Bristol-Myers Squibb
BMY
$0.42 (-0.89%)
1D
1W
3M
1Y
5Y
ALL
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It Read More...Read Less
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 1 day ago • BMY
Bristol Myers Squibb Announces DividendZacks Investment Research • 2 days ago • BMY
Bristol Myers Squibb (BMY) Stock Drops Despite Market Gains: Important Facts to NoteThe Motley Fool • 2 days ago • BMY
2 Beaten-Down Dividend Stocks to Buy Right NowZacks Investment Research • 5 days ago • BMY
BMY Focuses on Label Expansion of Drugs: Will This Revive Growth?Zacks Investment Research • 6 days ago • BMY
BMY Reports Positive Data on Sotyktu From Arthritis StudyCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.